Yu Lin

1.2k total citations
26 papers, 813 citations indexed

About

Yu Lin is a scholar working on Oncology, Molecular Biology and Cancer Research. According to data from OpenAlex, Yu Lin has authored 26 papers receiving a total of 813 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 7 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Yu Lin's work include Cancer Immunotherapy and Biomarkers (5 papers), Glioma Diagnosis and Treatment (3 papers) and MicroRNA in disease regulation (3 papers). Yu Lin is often cited by papers focused on Cancer Immunotherapy and Biomarkers (5 papers), Glioma Diagnosis and Treatment (3 papers) and MicroRNA in disease regulation (3 papers). Yu Lin collaborates with scholars based in China, United States and Germany. Yu Lin's co-authors include Akash Patnaik, Edison T. Liu, Brian M. Olson, Yadi Li, Xuejun Yang, Shengping Yu, Meng Zhu, Hao Yang, Pengfei Zhao and Haiwen Ma and has published in prestigious journals such as SHILAP Revista de lepidopterología, Frontiers in Immunology and Journal of Cellular Physiology.

In The Last Decade

Yu Lin

23 papers receiving 810 citations

Peers

Yu Lin

ONCOL

IMMUN

PRM

Bo Pang China

Cecilia Herráiz Spain

Xuexiang Wang China

June Ho Shin United States

Qingnan Zhao China

Jenny H. Pan United States

Guido Gambara Italy

Nathaniel Weygant United States

Laura Hüser Germany

Yupeng Wang China

Bo Pang China

Yu Lin

521 ×1.5

295 ×0.9

ONCOL

220 ×0.9

IMMUN

280 ×1.3

368 ×3.1

PRM

Citations per year, relative to Yu Lin Yu Lin (= 1×) peers Bo Pang

Countries citing papers authored by Yu Lin

Since Specialization

Citations

This map shows the geographic impact of Yu Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Lin more than expected).

Fields of papers citing papers by Yu Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Lin. The network helps show where Yu Lin may publish in the future.

Co-authorship network of co-authors of Yu Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Lin. A scholar is included among the top collaborators of Yu Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Lin. Yu Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Wang, Huimei, Yiping Zhang, Lin Chen, et al.. (2022). Identification of clinical prognostic features of esophageal cancer based on m6A regulators. Frontiers in Immunology. 13. 950365–950365. 14 indexed citations

Long, Junyu, Peipei Chen, Xiaobo Yang, et al.. (2022). Co-expression of receptor tyrosine kinases and CD8 T-lymphocyte genes is associated with distinct prognoses, immune cell infiltration patterns and immunogenicity in cancers. Translational research. 256. 14–29. 5 indexed citations

Rao, Xi, Xi Zhang, Gang Wu, et al.. (2022). Case Report: Complete Remission of a Patient With Metastatic Gastric Cancer Treated With Nivolumab Combined With Chemotherapy After Palliative Surgery. Frontiers in Immunology. 13. 908558–908558. 5 indexed citations

Li, Ting, Jun Xiao, Jing Wang, et al.. (2022). Tumor Microenvironment Profiling Identifies Prognostic Signatures and Suggests Immunotherapeutic Benefits in Neuroblastoma. Frontiers in Cell and Developmental Biology. 10. 814836–814836. 5 indexed citations

Long, Junyu, Dongxu Wang, Anqiang Wang, et al.. (2022). A mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscape. Genome Medicine. 14(1). 20–20. 37 indexed citations

Long, Junyu, Dongxu Wang, Xu Yang, et al.. (2021). Identification of NOTCH4 mutation as a response biomarker for immune checkpoint inhibitor therapy. BMC Medicine. 19(1). 154–154. 39 indexed citations

Tong, Luqing, Jiabo Li, Xuya Wang, et al.. (2020). ACT001 reduces the expression of PD-L1 by inhibiting the phosphorylation of STAT3 in glioblastoma. Theranostics. 10(13). 5943–5956. 112 indexed citations

Lin, Yu & Xuejun Yang. (2019). Application of tumor⁃treating fields method in the treatment of glioblastoma: from basic to clinical. SHILAP Revista de lepidopterología. 1 indexed citations

Yuan, Feng, Haolang Ming, Yingshuai Wang, et al.. (2019). Molecular and clinical characterization of Galectin‐9 in glioma through 1,027 samples. Journal of Cellular Physiology. 235(5). 4326–4334. 39 indexed citations

10.

Long, Hai, Peidong Liu, Shengping Yu, et al.. (2018). Jagged1 is Clinically Prognostic and Promotes Invasion of Glioma-Initiating Cells by Activating NF-κB(p65) Signaling. Cellular Physiology and Biochemistry. 51(6). 2925–2937. 18 indexed citations

11.

Long, Hai, Tao Li, Xingchen Zhou, et al.. (2018). Notch1 is a prognostic factor that is distinctly activated in the classical and proneural subtype of glioblastoma and that promotes glioma cell survival via the NF-κB(p65) pathway. Cell Death and Disease. 9(2). 158–158. 63 indexed citations

12.

Lin, Yu, et al.. (2018). Radiation exposure triggers the progression of triple negative breast cancer via stabilizing ZEB1. Biomedicine & Pharmacotherapy. 107. 1624–1630. 8 indexed citations

13.

Olson, Brian M., Yadi Li, Yu Lin, Edison T. Liu, & Akash Patnaik. (2018). Mouse Models for Cancer Immunotherapy Research. Cancer Discovery. 8(11). 1358–1365. 289 indexed citations

14.

Zhang, Kai, Yu Lin, Shuai Li, et al.. (2017). Location study of hand motor cortex by using navigated transcranial magnetic stimulation. Zhonghua shiyan waike zazhi. 34(8). 1281–1284.

15.

Lin, Yu, Kai Zhang, Shuai Li, et al.. (2017). Relationship Between Perisylvian Essential Language Sites and Arcuate Fasciculus in the Left Hemisphere of Healthy Adults. Neuroscience Bulletin. 33(6). 616–626. 8 indexed citations

16.

Zhang, Chen, Hai Long, Meng Zhu, et al.. (2017). Actin cytoskeleton regulator Arp2/3 complex is required for DLL1 activating Notch1 signaling to maintain the stem cell phenotype of glioma initiating cells. Oncotarget. 8(20). 33353–33364. 31 indexed citations

17.

Lin, Yu, Kai Zhang, Shuai Li, et al.. (2016). Mapping language eloquent cortices in Chinese: a navigated transcranial magnetic stimulation study. Chinese Journal of Neuromedicine. 15(4). 366–370.

18.

Yang, Hao, et al.. (2016). Increased MALAT1 expression predicts poor prognosis in esophageal cancer patients. Biomedicine & Pharmacotherapy. 83. 8–13. 38 indexed citations

19.

Wang, Ming, Xiaoyang Zhu, Liang Wang, & Yu Lin. (2015). Expression and Significance of CDC25B, PED/PEA-15 in Esophageal Carcinoma. Cancer Biotherapy and Radiopharmaceuticals. 30(3). 139–145. 9 indexed citations

20.

Zhu, Meng, Lei Chen, Pengfei Zhao, et al.. (2014). Store-operated Ca2+ entry regulates glioma cell migration and invasion via modulation of Pyk2 phosphorylation. Journal of Experimental & Clinical Cancer Research. 33(1). 98–98. 53 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact